KEVIN BEDWELL: Open Payments
NPI 1245250398 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 35 payments from 10 companies in 2025. Trend: 2023 $300 · 2024 $546 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $157 |
| Indivior Inc. | 8 | $137 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Collegium Pharmaceutical, Inc. | 4 | $88 |
| Braeburn Inc. | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $43 |
| Orexo US, Inc. | 2 | $40 |
| Valinor Pharma, LLC | 2 | $33 |
| Tonix Medicines, Inc. | 1 | $25 |
| Ethicon US, LLC | 1 | $25 |
Products named: SUBLOCADE, BOTOX, INGREZZA, Belbuca, BRIXADI, Zubsolv, MOVANTIK, TONMYA.
Industry payments across MD — which companies pay providers there.
